Iranian Team Wins Gold for Alzheimer's Early Detection Tool

Early detection could change everything for the 55 million people worldwide living with Alzheimer's disease, and a breakthrough from Iranian researchers just brought that possibility closer to reality.

A seven-person team of doctors and scientists from Iran won the gold medal at Thailand's International Intellectual Property, Invention, Innovation and Technology Exposition (IPITEX) in January 2026. Their invention, OligoTau-Select™, is a precision radiotracer that works with standard PET-MRI brain scans to detect harmful tau protein clusters linked to Alzheimer's before clinical symptoms emerge.

The technology addresses one of medicine's biggest challenges in fighting Alzheimer's. By the time most patients receive a diagnosis, irreversible brain damage has already occurred. This new tool could identify the disease during what researchers call the "preclinical" stage, when interventions might actually prevent or slow progression.

The team combined expertise from neuroscience, artificial intelligence, pharmaceutical engineering, and medical imaging. Lead researcher Dr. Reza Mosaddeghi Heris has published over 50 papers in top medical journals including The Lancet. Team member Dr. Niloofar Taheri now continues her work as a postdoctoral researcher at Stanford University, while Dr. Hanie Karimi recently joined the University of Michigan's research team.

Hamed Aghazadeh, CEO of NoyanGen Biotechnology Research Company and one of the inventors, emphasized the global significance. The National Research Council of Thailand presented the award at BITEC Bangkok from January 5 to 9, with support from the World Intellectual Property Organization and the International Federation of Inventors' Associations.

The Ripple Effect

This win represents more than one team's achievement. It demonstrates how international scientific collaboration continues to thrive, with researchers from Iran working alongside institutions in the United States and presenting innovations on the world stage in Thailand.

The technology could eventually help millions of families prepare for and potentially prevent the devastating progression of Alzheimer's. Current treatments work best when started early, but doctors rarely catch the disease at that stage. OligoTau-Select™ could change that equation entirely.

Several team members have already emigrated to continue their research at major American universities, spreading this expertise across borders. Their combined work on brain imaging, neurology, and AI-powered diagnostics positions them to keep pushing boundaries in neurological disease detection.

One invention at a time, researchers around the world are turning Alzheimer's from an inevitable decline into a disease we might actually outsmart.